You are here: All Products  > Dizal’s JAK1 Inhibitor NDA Accepted for China Review as PTCL Therapy

Dizal’s JAK1 Inhibitor NDA Accepted for China Review as PTCL Therapy

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.